#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Immune thrombocytopenia Erythema Waldenstrom's macroglobulinaemia Non-small cell lung cancer recurrent ABO haemolytic disease of newborn Hyperchylomicronaemia Chronic graft versus host disease in skin Vitamin B12 deficiency Familial haemophagocytic lymphohistiocytosis Antisynthetase syndrome Adrenoleukodystrophy Paget's disease of the vulva Neoplasm malignant Non-Hodgkin's lymphoma unspecified histology aggressive recurrent More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors Aicardi-Goutieres syndrome Crigler-Najjar syndrome Breast angiosarcoma – Diagnostics Erdheim-Chester disease – Basic Information Pleural mesothelioma malignant – Diagnostics Langerhans cell sarcoma – Treatment Pemphigus Synovial sarcoma metastatic – Diagnostics Familial amyotrophic lateral sclerosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxycodone Hydrochloride Feladilimab SONLICROMANOL HYDROCHLORIDE Diazepam Aminohippuric Acid Anhydrous Caffeine Mps-213 Absk021 Hydrochloride Hydrate Pelareorep Cefotaxime Vib1116 Tolcapone Sapropterin Dihydrochloride Ascorbic Acid Ulonivirine Emapalumab AAV9-CTNT-COBAG3 Cenerimod SOFOSBUVIR Human Coagulation Factor X More therapies…

    Learn about Your Condition

    Hip arthroplasty Cytokine release syndrome Anal cancer recurrent Alveolar rhabdomyosarcoma Mitral valve disease Diabetic foot infection Febrile neutropenia Urticaria cholinergic Epstein-Barr virus infection Lung adenocarcinoma stage IV Hyperphagia Mental disorder Diabetic gastroparesis HIV infection Myocarditis post infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Psychiatricka Nemocnica Philippa Pinela Pezinok

Psychiatricka Nemocnica Philippa Pinela Pezinok

Malacka Cesta 63, Pezinok, 902 01, Slovakia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer’s-Related Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia France Germany Greece +7

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!